9:40AM ET 11/10/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
6:01AM ET 8/25/2022 MT NewswiresProtagonist Therapeutics (PTGX) has an average rating of outperform and price targets ranging from $21 to $50, according to analysts polled by Capital IQ....
6:52AM ET 5/18/2022 MT NewswiresProtagonist Therapeutics (PTGX) has an average rating of buy and price targets ranging from $30 to $60, according to analysts polled by Capital IQ. (MT...
10:00AM ET 5/05/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...